<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36915802</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2312-0541</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>ERJ open research</Title><ISOAbbreviation>ERJ Open Res</ISOAbbreviation></Journal><ArticleTitle>A prospective study of pulmonary outcomes and chest computed tomography in the first year after COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">00575-2022</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/23120541.00575-2022</ELocationID><Abstract><AbstractText>COVID-19 primarily affects the respiratory system. We aimed to evaluate how pulmonary outcomes develop after COVID-19 by assessing participants from the first pandemic wave prospectively 3 and 12&#x2005;months following hospital discharge. Pulmonary outcomes included self-reported dyspnoea assessed with the modified Medical Research Council dyspnoea scale, 6-min walk distance (6MWD), spirometry, diffusing capacity of the lung for carbon monoxide (<i>D</i> <sub>LCO</sub>), body plethysmography and chest computed tomography (CT). Chest CT was repeated at 12&#x2005;months in participants with pathological findings at 3&#x2005;months. The World Health Organization (WHO) ordinal scale for clinical improvement defined disease severity in the acute phase. Of 262 included COVID-19 patients, 245 (94%) and 222 (90%) participants attended the 3- and 12-month follow-up, respectively. Self-reported dyspnoea and 6MWD remained unchanged between the two time points, while <i>D</i> <sub>LCO</sub> and total lung capacity improved (0.28&#x2005;mmol&#xb7;min<sup>-1</sup>&#xb7;kPa<sup>-1</sup>, 95% CI 0.12-0.44, and 0.13&#x2005;L, 95% CI 0.02-0.24, respectively). The prevalence of fibrotic-like findings on chest CT at 3 and 12&#x2005;months in those with follow-up chest CT was unaltered. Those with more severe disease had worse dyspnoea, <i>D</i> <sub>LCO</sub> and total lung capacity values than those with mild disease. There was an overall positive development of pulmonary outcomes from 3 to 12&#x2005;months after hospital discharge. The discrepancy between the unaltered prevalence of self-reported dyspnoea and the improvement in pulmonary function underscores the complexity of dyspnoea as a prominent factor of long-COVID. The lack of increase in fibrotic-like findings from 3 to 12&#x2005;months suggests that SARS-CoV-2 does not induce a progressive fibrotic process in the lungs.</AbstractText><CopyrightInformation>Copyright &#xa9;The authors 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lerum</LastName><ForeName>T&#xf8;ri Vigeland</ForeName><Initials>TV</Initials><Identifier Source="ORCID">0000-0001-8326-9993</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meltzer</LastName><ForeName>Carin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Jezabel Riverio</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aal&#xf8;kken</LastName><ForeName>Trond Mogens</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Institute for Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Br&#xf8;nstad</LastName><ForeName>Eivind</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Thoracic Department, St Olav's Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aarli</LastName><ForeName>Bernt B</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aarberg-Lund</LastName><ForeName>Kristine Marie</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, &#xd8;stfold Hospital Trust Kalnes, Gr&#xe5;lum, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durheim</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Institute for Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashraf</LastName><ForeName>Haseem</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute for Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Diagnostic Imaging, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Einvik</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pulmonary Department, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skj&#xf8;nsberg</LastName><ForeName>Ole Henning</ForeName><Initials>OH</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stavem</LastName><ForeName>Knut</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4512-8000</Identifier><AffiliationInfo><Affiliation>Institute for Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pulmonary Department, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Services Research Unit, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ERJ Open Res</MedlineTA><NlmUniqueID>101671641</NlmUniqueID><ISSNLinking>2312-0541</ISSNLinking></MedlineJournalInfo><CoiStatement>Conflict of interest: T.V. Lerum has nothing to disclose. Conflict of interest: C. Meltzer has nothing to disclose. Conflict of interest: J.R. Rodriguez has nothing to disclose. Conflict of interest: T.M. Aal&#xf8;kken has nothing to disclose. Conflict of interest: E. Br&#xf8;nstad has nothing to disclose. Conflict of interest: B.B. Aarli reports personal fees for lectures and advisory board work from AstraZeneca, personal fees for lectures from GlaxoSmithKline, Novartis, Boehringer Ingelheim and Chiesi Pharma, outside the submitted work. Conflict of interest: K.M. Aarberg-Lund has nothing to disclose. Conflict of interest: M.T. Durheim reports grants to his institution and personal fees from Boehringer Ingelheim and Roche, and personal fees from AstraZeneca, outside the submitted work. Conflict of interest: H. Ashraf reports grants from Boehringer Ingelheim, during the conduct of the study. Conflict of interest: G. Einvik reports grants from Boehringer Ingelheim, during the conduct of the study; and personal fees for consultancy from AstraZeneca AB, outside the submitted work. Conflicts of interest: O.H. Skj&#xf8;nsberg has nothing to disclose. Conflict of interest: K. Stavem reports fees from UCB Pharma and MSD, outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>2</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36915802</ArticleId><ArticleId IdType="pmc">PMC9790092</ArticleId><ArticleId IdType="doi">10.1183/23120541.00575-2022</ArticleId><ArticleId IdType="pii">00575-2022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed H, Patel K, Greenwood DC, et al. . Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med 2020; 52: jrm00063.</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler SA, Ebner L, Aubry-Beigelman C, et al. . Pulmonary function and radiological features 4&#x2005;months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J 2021; 57: 2003690. doi:10.1183/13993003.03690-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerum TV, Aalokken TM, Bronstad E, et al. . Dyspnoea, lung function and CT findings three months after hospital admission for COVID-19. Eur Respir J 2020; 57: 2003448. doi:10.1183/13993003.03448-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03448-2020</ArticleId><ArticleId IdType="pmc">PMC7736755</ArticleId><ArticleId IdType="pubmed">33303540</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerum TV, Maltzahn NN, Aukrust P, et al. . Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9. Sci Rep 2021; 11: 23205. doi:10.1038/s41598-021-02547-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-02547-x</ArticleId><ArticleId IdType="pmc">PMC8636497</ArticleId><ArticleId IdType="pubmed">34853380</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, et al. . 3-month, 6&#x2013;month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med 2021; 9: 747&#x2013;754. doi:10.1016/S2213-2600(21)00174-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. . 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021; 398: 747&#x2013;758. doi:10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Thannickal VJ, Toews GB, White ES, et al. . Mechanisms of pulmonary fibrosis. Annu Rev Med 2004; 55: 395&#x2013;417. doi:10.1146/annurev.med.55.091902.103810</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.med.55.091902.103810</ArticleId><ArticleId IdType="pubmed">14746528</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WJ, Tang XX. Virus infection induced pulmonary fibrosis. J Transl Med 2021; 19: 496. doi:10.1186/s12967-021-03159-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03159-9</ArticleId><ArticleId IdType="pmc">PMC8649310</ArticleId><ArticleId IdType="pubmed">34876129</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger AK, Sonnweber T, Gruber L, et al. . Chest CT of lung injury 1 year after COVID-19 pneumonia: the CovILD study. Radiology 2022; 304: 462&#x2013;470. doi:10.1148/radiol.211670</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.211670</ArticleId><ArticleId IdType="pmc">PMC8988857</ArticleId><ArticleId IdType="pubmed">35348379</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Solidarity Trial Consortium ; Pan H, Peto R, et al. . Repurposed antiviral drugs for covid-19 &#x2013; interim WHO Solidarity Trial results. N Engl J Med 2021; 384: 497&#x2013;511. doi:10.1056/NEJMoa2023184</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2023184</ArticleId><ArticleId IdType="pmc">PMC7727327</ArticleId><ArticleId IdType="pubmed">33264556</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams N. The MRC breathlessness scale. Occup Med (Lond) 2017; 67: 496&#x2013;497. doi:10.1093/occmed/kqx086</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqx086</ArticleId><ArticleId IdType="pubmed">28898975</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher CM, Elmes PC, Fairbairn AS, et al. . The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959; 2: 257&#x2013;266. doi:10.1136/bmj.2.5147.257</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.2.5147.257</ArticleId><ArticleId IdType="pmc">PMC1990153</ArticleId><ArticleId IdType="pubmed">13823475</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Steenbruggen I, Miller MR, et al. . Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med 2019; 200: e70&#x2013;e88. doi:10.1164/rccm.201908-1590ST</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201908-1590ST</ArticleId><ArticleId IdType="pmc">PMC6794117</ArticleId><ArticleId IdType="pubmed">31613151</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Brusasco V, Burgos F, et al. . 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J 2017; 49: 1600016. doi:10.1183/13993003.00016-2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00016-2016</ArticleId><ArticleId IdType="pubmed">28049168</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland AE, Spruit MA, Troosters T, et al. . An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014; 44: 1428&#x2013;1446. doi:10.1183/09031936.00150314</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00150314</ArticleId><ArticleId IdType="pubmed">25359355</ArticleId></ArticleIdList></Reference><Reference><Citation>Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998; 158: 1384&#x2013;1387. doi:10.1164/ajrccm.158.5.9710086</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.158.5.9710086</ArticleId><ArticleId IdType="pubmed">9817683</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojevic S, Graham BL, Cooper BG, et al. . Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J 2017; 50: 1700010. doi:10.1183/13993003.00010-2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00010-2017</ArticleId><ArticleId IdType="pubmed">28893868</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer PH, Stanojevic S, Cole TJ, et al. . Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324&#x2013;1343. doi:10.1183/09031936.00080312</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00080312</ArticleId><ArticleId IdType="pmc">PMC3786581</ArticleId><ArticleId IdType="pubmed">22743675</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansell DM, Bankier AA, MacMahon H, et al. . Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246: 697&#x2013;722. doi:10.1148/radiol.2462070712</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2462070712</ArticleId><ArticleId IdType="pubmed">18195376</ArticleId></ArticleIdList></Reference><Reference><Citation>Soyseth V, Aalokken TM, Mynarek G, et al. . Diagnosis of biopsy verified usual interstitial pneumonia by computed tomography. Respir Med 2015; 109: 897&#x2013;903. doi:10.1016/j.rmed.2015.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2015.05.008</ArticleId><ArticleId IdType="pubmed">26028484</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, et al. . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373&#x2013;383. doi:10.1016/0021-9681(87)90171-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis 2020; 20: e192&#x2013;e197. doi:10.1016/S1473-3099(20)30483-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R, Viegi G, Brusasco V, et al. . Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948&#x2013;968. doi:10.1183/09031936.05.00035205</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00035205</ArticleId><ArticleId IdType="pubmed">16264058</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise RA, Brown CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD 2005; 2: 125&#x2013;129. doi:10.1081/COPD-200050527</Citation><ArticleIdList><ArticleId IdType="doi">10.1081/COPD-200050527</ArticleId><ArticleId IdType="pubmed">17136972</ArticleId></ArticleIdList></Reference><Reference><Citation>Ovrebotten T, Myhre P, Grimsmo J, et al. . Changes in cardiac structure and function from 3 to 12 months after hospitalization for COVID-19. Clin Cardiol 2022; 45: 1044&#x2013;1052. doi:10.1002/clc.23891</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23891</ArticleId><ArticleId IdType="pmc">PMC9538691</ArticleId><ArticleId IdType="pubmed">35920837</ArticleId></ArticleIdList></Reference><Reference><Citation>Skjorten I, Ankerstjerne OAW, Trebinjac D, et al. . Cardiopulmonary exercise capacity and limitations 3&#x2005;months after COVID-19 hospitalisation. Eur Respir J 2021; 58: 2100996. doi:10.1183/13993003.00996-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00996-2021</ArticleId><ArticleId IdType="pmc">PMC8247555</ArticleId><ArticleId IdType="pubmed">34210791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini DM, Brunjes DL, Lala A, et al. . Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail 2021; 9: 927&#x2013;937. doi:10.1016/j.jchf.2021.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingul CB, Edvardsen A, Follestad T, et al. . Changes in cardiopulmonary exercise capacity and limitations 3 to 12 months after COVID-19. Eur Respir J 2022; in press [10.1183/13993003.00745-2022].</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00745-2022</ArticleId><ArticleId IdType="pmc">PMC9515478</ArticleId><ArticleId IdType="pubmed">36137587</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. . &#x2018;Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 2021; 76: 396&#x2013;398. doi:10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Li J, Liu H, et al. . Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res 2020; 8: 8. doi:10.1038/s41413-020-0084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41413-020-0084-5</ArticleId><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorent N, Vande Weygaerde Y, Claeys E, et al. . Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge. ERJ Open Res 2022; 8: 00004-2022. doi:10.1183/23120541.00004-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00004-2022</ArticleId><ArticleId IdType="pmc">PMC8994962</ArticleId><ArticleId IdType="pubmed">35415186</ArticleId></ArticleIdList></Reference><Reference><Citation>Criee CP, Sorichter S, Smith HJ, et al. . Body plethysmography: its principles and clinical use. Respir Med 2011; 105: 959&#x2013;971. doi:10.1016/j.rmed.2011.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2011.02.006</ArticleId><ArticleId IdType="pubmed">21356587</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo HJ, Lim S, Choe J, et al. . Radiographic and CT features of viral pneumonia. Radiographics 2018; 38: 719&#x2013;739. doi:10.1148/rg.2018170048</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/rg.2018170048</ArticleId><ArticleId IdType="pubmed">29757717</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>